首页> 美国卫生研究院文献>Human Gene Therapy Methods >Correlates Between Host and Viral Transcriptional Program Associated with Different Oncolytic Vaccinia Virus Isolates
【2h】

Correlates Between Host and Viral Transcriptional Program Associated with Different Oncolytic Vaccinia Virus Isolates

机译:与宿主和病毒转录程序与不同的溶瘤痘苗病毒分离株相关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccinia virus (VACV) has emerged as an attractive tool in oncolytic virotherapy. VACV replication efficiency plays a crucial role in the therapeutic outcome. However, little is known about the influence of host factors on viral replication efficiency and permissiveness of a host cell line to infection and oncolysis. In this study, replication of the attenuated VACV GLV-1h68 strain and three wild-type VACV isolates was determined in two autologous human melanoma cell lines (888-MEL and 1936-MEL). Host gene expression and viral gene expression in infected cells were evaluated via respective expression array platforms.Microarray analyses followed by sequential statistical approaches characterized human genes that change specifically due to virus infection. Viral gene transcription correlated with viral replication in a time-dependent manner. A set of human genes revealed strong correlations with the respective viral gene expression. Finally we identified a set of human genes with possible predictive value for viral replication in an independent dataset.The results demonstrate a probable correlation between viral replication, early gene expression, and the respective host response, and thus a possible involvement of human host factors in viral early replication. The characterization of human target genes that influence viral replication could help answer the question of host cell permissiveness to oncolytic virotherapy and provide important information for the development of novel recombinant vaccinia viruses with improved features to enhance replication rate and hence trigger therapeutic outcome.
机译:牛痘病毒(VACV)已成为溶瘤病毒疗法中一种有吸引力的工具。 VACV复制效率在治疗结果中起着至关重要的作用。然而,关于宿主因子对病毒复制效率以及宿主细胞系对感染和溶瘤的允许性的影响知之甚少。在这项研究中,在两个自体人类黑素瘤细胞系(888-MEL和1936-MEL)中确定了减毒的VACV GLV-1h68菌株和三个野生型VACV分离株的复制。通过各自的表达阵列平台评估宿主细胞中宿主基因的表达和病毒基因的表达。微阵列分析和随后的统计方法表征了由于病毒感染而特异性改变的人类基因。病毒基因转录以时间依赖性方式与病毒复制相关。一组人类基因显示出与各自病毒基因表达的强相关性。最后,我们在独立的数据集中确定了一组对病毒复制具有预测价值的人类基因,结果证明了病毒复制,早期基因表达和各自的宿主反应之间可能存在相关性,因此人类宿主因子可能参与其中。病毒早期复制。影响病毒复制的人类靶基因的表征可以帮助回答宿主细胞对溶瘤病毒疗法的允许性问题,并为开发新型改良重组牛痘病毒提供重要信息,这些新型痘苗病毒具有增强的复制率并因此触发治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号